Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1438]
News [2924]
Articles [126]
Editorials [5]
Conferences [154]
elearning [6]
TGR-1202, ublituximab and ibrutinib combination for advanced CLL and NHL
Dr Loretta Nastoupil - MD Anderson Cancer Center, Houston, USA
TGR-1202, ublituximab and ibrutinib combination for advanced CLL and NHL ( Dr Loretta Nastoupil - MD Anderson Cancer Center, Houston, USA )
24 Jun 2017
ESMO ranking of the clinical benefits of new drugs
Prof Alberto Sobrero - Ospedale San Martino, Genova, Italy
ESMO ranking of the clinical benefits of new drugs ( Prof Alberto Sobrero - Ospedale San Martino, Genova, Italy )
19 Jun 2017
Gastrectomy and oral drug prescription
Prof Alain Astier – Universidad de Paris, Paris, France
Gastrectomy and oral drug prescription ( Prof Alain Astier – Universidad de Paris, Paris, France )
14 Jun 2017
Stereotactic radiotherapy in primary hepatic cancer
Dr Parag Parikh - Washington University, St. Louis, USA
Stereotactic radiotherapy in primary hepatic cancer ( Dr Parag Parikh - Washington University, St. Louis, USA )
13 Jun 2017
(1/6) ASCO 2017: Introduction to Expert discussion on the latest in prostate...
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(1/6) ASCO 2017: Introduction to Expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(2/6) ASCO 2017: LATITUDE data
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(2/6) ASCO 2017: LATITUDE data ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(3/6) ASCO 2017: STAMPEDE data
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(3/6) ASCO 2017: STAMPEDE data ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(4/6) ASCO 2017: Expert discussion on the latest in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(4/6) ASCO 2017: Expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(5/6) ASCO 2017: ASCO highlights in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(5/6) ASCO 2017: ASCO highlights in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
(6/6) ASCO 2017: Round up of expert discussion on the latest in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
(6/6) ASCO 2017: Round up of expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
12 Jun 2017
New ALK inhibitor alectinib halts lung cancer growth more than a year longer...
Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
New ALK inhibitor alectinib halts lung cancer growth more than a year longer than crizotinib, with fewer severe side effects ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
5 Jun 2017
ASCO 2017: Expert discussion on the latest in prostate cancer
Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James
ASCO 2017: Expert discussion on the latest in prostate cancer ( Dr Neal Shore, Prof Karim Fizazi, Prof Kurt Miller and Prof Nicholas James )
5 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation